IndiaFilingsIndiaFilings
India FlagRegister India Company
UAE FlagRegister UAE Company
USA FlagRegister USA Company

AYURVEDA SIDDHA KALPA PHARMACEUTICALS LLP

LLPIN : ACA-8407|ROC: RoC-ErnakulamActive
Last Updated On : 28-04-2023
LLPINACA-8407
LLP NameAYURVEDA SIDDHA KALPA PHARMACEUTICALS LLP
Number of Partners2
Number of Designated Partners2
ROC CodeRoC-Ernakulam
Date of Incorporation28-04-2023
Registered Address197B, ERUVATH KIZHAKKETHODI HOUSE CHELAKKAD POST, KATTUPPARA Chelakkad Perinthalmanna Malappuram Kerala 679323
Email IDfinzoservices@gmail.com
Total Obligation of Contribution50,000
Main division of business activity to be carried out in India86
LLP StatusActive

Directors / Signatory Details

DIN / PANNameBegin Date
10139207 ERUVATH KIZHAKKETHODI SHAJI28-04-2023
10139208ABDUL SALAM28-04-2023
AYURVEDA SIDDHA KALPA PHARMACEUTICALS LLP is a Limited Liability Partnership (LLP) governed by the LLP Act, 2008. Registered under the Registrar of Companies RoC-Ernakulam, it operates as a non-government entity. According to the Ministry of Corporate Affairs (MCA), this LLP was incorporated on 28-04-2023 and last updated on 28-04-2023. Its LLP Identification Number (LLPIN) is , and the registration number is . Currently, its eFiling status is listed as “Active” as per MCA records.
From a financial standpoint, AYURVEDA SIDDHA KALPA PHARMACEUTICALS LLP has a total contribution of INR 50,000. Details of the latest financial filings, such as the Statement of Accounts and Solvency or Annual Returns, are unavailable, indicating limited publicly disclosed financial data.
The registered office address is 197B, ERUVATH KIZHAKKETHODI HOUSE CHELAKKAD POST, KATTUPPARA Chelakkad Perinthalmanna Malappuram Kerala 679323. Correspondence or inquiries may be sent to the official email address, finzoservices@gmail.com.
For those interested in further details, below are some frequently asked questions:
Disclaimer

IndiaFilings is not affiliated with any companies listed on this website and does not represent them. Please contact the respective company directly for their inquiries.